Losses
-€11,944 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
GrO2
Lifetime
3 annual accounts with figures on one time axispeak €13,366 (2023)
-€2,072▲ €2,753
lowest -€7,137 (2024)
-€4,807▲ €2,329
peak €32,801 (2023)
€20,856▼ 18.7%
€1,506▲ 2.8%
Board2 names since 2022
2 directorsBOVEN Arthur and 1 other
Documentsfilings and deeds
01-06-202660 days before the deadline
2025micro format
Gross margin from -€4,825 to -€2,072Loss of €4,807Equity from €25,664 to €20,856
Key points
from the 2025 annual accountsStarting capital
€21,600 12,000 shares
Position in the sector
93.3%
Higher solvency than 88% of companies in research and development. Sector median 60.4% · 620 companies.
Turnover not published (micro format)
Checked score
94
Excellent
Financially stronger than 54% of micro companies in research and development (NACE 72)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.1% across 932 companies (NACE 72, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: 0.1%● unchanged vs 12-2024lowest value
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.1%● unchanged vs 06-2025
08-2025: 0.1%● unchanged vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.2%▲ +0.1 percentage points vs 04-2026highest value
06-2026: 0.1%▼ -0.1 percentage points vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.1%● unchanged vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
11-2026: 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Liquidity: current ratio 13.16, cash €19,763
Sector: Scientific research and development (NACE 72)
Equity €20,856 (93.3% of total assets)
Figures for financial year 2025 (filed on 01-06-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 96% on liquidity, 10% on profitability and 27% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,223 companies had the same profile as GrO2 has now. Each dot stands for 9 companies, two years later.
87.8%
were still trading
8.7%
stopped another way
3.4%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of GrO2 itself is lower: 0.1% within 12 months. It rests on far more data about GrO2 than the profile alone.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,223 companies, not a prediction for GrO2. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 13.16 (15.36 in 2024), above the usual 1.5. Short-term debt is 6.7% and cash 88.4% of total assets. 6.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
232425
2023 to 2025 · latest year -€4,807
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
60 days early
2024
59 days early
2023
55 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 3 accounts on average 58 days before the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 2 June (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- BOVEN Dirk founderdeed of 10-10-2022
- BOVEN Arthur founderdeed of 10-10-2022
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0792145055
Incorporation
Founding capital of €21,600, 12,000 shares, €5,000 paid up · Founders: BOVEN Dirk and BOVEN Arthur · Appointments: BOVEN Dirk (director) and BOVEN Arthur (director) · published on 10-10-2022 · Gazette deed
First establishment
St.-Apollonialaan 76, Mol
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| GrO2 Mol | €22,362 | -€2,072 | 93.3% | - |
| SPECIFIX Antwerp | €20,090 | -€155,139 | -637.1% | - |
| Suomidoc Schoten | €27,262 | -€4,294 | -4.5% | - |
| AtomX Chastre | €32,717 | -€15,630 | 67.5% | - |
| HAPPY DIAB Binche | €29,576 | -€2,537 | 30.9% | - |
| Immunofusion Charleroi | €32,131 | -€42,496 | -392.3% | 0 |
| PR CONSULT Namur | €35,375 | -€27,733 | -27.1% | - |
These companies have the same main activity as GrO2: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €20,100 and €35,400, founded between 2021 and 2024.
Official details
Source: KBO- Status
- Active since 06-10-2022Normal situation
- Activity
- Other research and development on natural sciencesNACE 72109
- Establishment unit
- 2.343.822.5792400 Mol, since 06-10-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Annual accounts 2025
- €22,362▼ 17.6%
- Filing
- Filed on 01-06-2026, 60 days before the end of the filing period
Insights on GrO2
GrO2 files the micro format. That format states no turnover. The gross margin fell from €13,366 in 2023 to -€2,072 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about GrO2
- What is the company number of GrO2?
- The company number of GrO2 is 0792.145.055. The VAT number is the same number with BE in front: BE 0792.145.055.
- Where is GrO2 based?
- The registered office is at St.-Apollonialaan 76, 2400 Mol.Company details
- What does GrO2 do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of GrO2?
- GrO2 is a private limited company (BV).
- When was GrO2 founded?
- GrO2 was founded on 06-10-2022.
- Is GrO2 still active?
- Yes, GrO2 is an active enterprise in the KBO register.
- What is the turnover of GrO2?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is GrO2 profitable?
- In financial year 2025, GrO2 made a loss of €4,807.
- Where can I find the annual accounts of GrO2?
- GrO2 filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of GrO2 due?
- GrO2 must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.